Correlation Between Shinhan Financial and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Shinhan Financial and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shinhan Financial and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shinhan Financial Group and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Shinhan Financial and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shinhan Financial with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shinhan Financial and Syndax Pharmaceuticals.
Diversification Opportunities for Shinhan Financial and Syndax Pharmaceuticals
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Shinhan and Syndax is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Shinhan Financial Group and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Shinhan Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shinhan Financial Group are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Shinhan Financial i.e., Shinhan Financial and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Shinhan Financial and Syndax Pharmaceuticals
Considering the 90-day investment horizon Shinhan Financial Group is expected to under-perform the Syndax Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Shinhan Financial Group is 2.29 times less risky than Syndax Pharmaceuticals. The stock trades about -0.24 of its potential returns per unit of risk. The Syndax Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 1,424 in Syndax Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 104.00 from holding Syndax Pharmaceuticals or generate 7.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Shinhan Financial Group vs. Syndax Pharmaceuticals
Performance |
Timeline |
Shinhan Financial |
Syndax Pharmaceuticals |
Shinhan Financial and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Shinhan Financial and Syndax Pharmaceuticals
The main advantage of trading using opposite Shinhan Financial and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shinhan Financial position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.Shinhan Financial vs. Community West Bancshares | ||
Shinhan Financial vs. First Financial Northwest | ||
Shinhan Financial vs. Ponce Financial Group | ||
Shinhan Financial vs. Finwise Bancorp |
Syndax Pharmaceuticals vs. Cogent Biosciences | ||
Syndax Pharmaceuticals vs. Cullinan Oncology LLC | ||
Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | ||
Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |